Pharmaceuticals

PHARMASOLVE™

Excipient for use in direct-compression tableting.Benefits:It is a water-miscible polar aprotic solvent with high interfacial activitySuitable as a solubilizer and penetration enhancer in human parenteral and topical-dosage forms, as well as parenteral and topical veterinary products

PHARMASOLVE™ 1

Solubilizer & penetration enhancer for human as well as veterinary parenteral and topical dosage forms. It is used as a solvent for preparation of two-component systems designed for long-acting drug release.Benefits:Helps to improve solubility of drugsEnhances bioavailabilityEXCiPACT GMP certifiedKosher certified, Vegan suitableMeets the requirements of current USP/NF, EP and JPE

PLASDONE™ C-12 1

Solubilizer and crystallization inhibitor suitable for parenteral dosage forms. It can be used as a binder for tablets.Benefits:Has low pyrogen levelEnhances bioavailabilityMeets the requirements of current US, European, Japanese, ChP pharmacopoeias

PLASDONE™ C-15

Excipient for use in crystallization inhibitor, drug solubilization, lyophilization stabilizer, liquid rheology modification, suspending agent.Benefits:Increased solubility and bioavailability of drugs activesQuickly dissolves in waterForms water-soluble bioadhesives and films

PLASDONE™ C-30

Excipient for use in crystallization inhibitor, drug solubilization, lyophilization stabilizer, liquid rheology modification, suspending agent.Benefits:Increased solubility and bioavailability of drugs activesQuickly dissolves in waterForms water-soluble bioadhesives and films

PLASDONE™ K-25

Excipient for use in crystallization inhibitor, drug solubilization, lyophilization stabilizer, liquid rheology modification, suspending agent.Benefits:Increased solubility and bioavailability of drugs activesQuickly dissolves in waterForms water-soluble bioadhesives and films

PLASDONE™ K-25 2 5602

Solubilizer used in solid dispersion pharmaceutical formulations. It acts as a crystallization inhibitor for liquid soft gels. It is also used as a binding agent in tablets.Benefits:Provides hard & non-friable tabletsImproves bioavailability

PLASDONE™ K-29/32

Excipient for use in crystallization inhibitor, drug solubilization, lyophilization stabilizer, liquid rheology modification, suspending agent.Benefits:Increased solubility and bioavailability of drugs activesQuickly dissolves in waterForms water-soluble bioadhesives and films